ArticleBlood advances2024
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.
Open access · goldAbstract read
In one paragraph
Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.
- Advances in rapid ADAMTS13 testing for thrombotic thrombocytopenic purpura: a systematic review of diagnostic assays and the role of clinical probability tools.Frontiers in medicine · 2026Pooled it
- Mortality prediction in immune TTP remains challenging despite artificial intelligence advances.Blood advances · 2026Article
- Clinical predictors of mortality in immune thrombotic thrombocytopenic purpura: A National Inpatient Sample analysis.British journal of haematology · 2026Article
- Trends in Clinical Indications for Plasma Exchange in Adult Patients Between 2008 and 2024 in Bogotá, Colombia.Journal of clinical apheresis · 2026Article
- Unmet health care needs in immune thrombotic thrombocytopenic purpura survivors.Research and practice in thrombosis and haemostasis · 2026Article
- Current standards and novel concepts in thrombotic thrombocytopenic purpura.Frontiers in medicine · 2026Review
- Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study.Journal of clinical medicine · 2024Article
- A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.Research and practice in thrombosis and haemostasis · 2024Article
- Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: a single-center retrospective analysis.Clinical and experimental medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors at 19 institutions in 2 countries.
Mouhamed Yazan Abou-IsmailDivision of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT.ORCID 0000-0002-6682-4366
Chong ZhangDivision of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
Angela P PressonDivision of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
Shruti ChaturvediDepartment of Medicine, Johns Hopkins University, Baltimore, MD.ORCID 0000-0001-6832-2389
Ana G AntunDepartment of Medicine, Emory University, Atlanta, GA.
Andrew M FarlandDepartment of Medicine, Wake Forest University, Winston-Salem, NC.
Ryan WoodsDepartment of Medicine, Wake Forest University, Winston-Salem, NC.
Ara MetjianDepartment of Medicine, University of Colorado, Denver, CO.ORCID 0000-0001-9890-8639
Yara A ParkDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC.
Gustaaf de RidderDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC.
Briana GibsonDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC.
Raj S KasthuriDepartment of Medicine, University of North Carolina, Chapel Hill, NC.ORCID 0000-0001-6672-3082
Darla K LilesDepartment of Medicine, East Carolina University, Greenville, NC.
Frank AkwaaDepartment of Medicine, University of Rochester, Rochester, NY.
Todd CloverHematology/Oncology, St. Charles Healthcare, Bend, OR.
Lisa Baumann KreuzigerVersiti Blood Center of Wisconsin, Milwaukee, WI.ORCID 0000-0002-1171-0548
Meera SridharanDepartment of Medicine, Mayo Clinic, Rochester, MN.ORCID 0000-0001-7225-8228
Ronald S GoDepartment of Medicine, Mayo Clinic, Rochester, MN.
Keith R McCraeDepartment of Medicine, Cleveland Clinic, Cleveland, OH.ORCID 0000-0001-7340-475X
Harsh Vardhan UpretiDepartment of Medicine, Johns Hopkins University, Baltimore, MD.
Radhika GangarajuDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-5542-4754
Nicole K KocherDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL.
X Long ZhengDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS.ORCID 0000-0003-1680-5295
Jay S RavalDepartment of Pathology, University of New Mexico, Albuquerque, NM.ORCID 0000-0001-9835-957X
Camila MasiasBaptist Health South Florida, Miami, FL.
Spero R CatalandDepartment of Medicine, The Ohio State University, Columbus, OH.ORCID 0000-0001-8977-6910
Andrew D JohnsonDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.
Elizabeth DavisDepartment of Medicine, University of Minnesota, Minneapolis, MN.
Michael D EvansClinical & Translational Science Institute, University of Minnesota, Minneapolis, MN.ORCID 0000-0001-7449-3993
Marshall MazepaDepartment of Medicine, University of Minnesota, Minneapolis, MN.ORCID 0000-0003-4294-3069
Ming Y LimDivision of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT.ORCID 0000-0001-5208-3387
University of Minnesota · USUniversity of North Carolina at Chapel Hill · USUniversity of Utah · USMayo Clinic in Arizona · USUniversity of Alabama at Birmingham · USWake Forest University · USBaptist Health South Florida · USCleveland Clinic · USEast Carolina University · USEmory University · USJohns Hopkins University · USMedical College of Wisconsin · USSt. Charles Medical Center · USThe Ohio State University · USUniversity of Colorado Denver · USUniversity of Delhi · INUniversity of Kansas Medical Center · USUniversity of New Mexico · USUniversity of Rochester · US
Funding
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0MCTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9MADAMTS13 and Late Neurologic Morbidity after Thrombotic Thrombocytopenic PurpuraK99HL150594 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CHATURVEDI, SHRUTI · 2020 to 2023
$907kClonal Hematopoiesis in a Biracial PopulationK08HL159290 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Radhika Gangaraju · 2022 to 2026
$820kNCATS NIH HHS UL1 TR002538NCATS NIH HHS UM1 TR004409NHLBI NIH HHS K08 HL159290NHLBI NIH HHS K99 HL150594
Abstract
PubMed holds no abstract for this paper.
Indexed as
Purpura, Thrombocytopenic, IdiopathicPurpura, Thrombotic ThrombocytopenicThrombosisHumansRegistries
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.